[Research Report] The transcranial magnetic stimulator (TMS) market is projected to reach US$ 2,029.71 million by 2028 from US$ 1,122.22 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.
Neurological disorders affect the brain and nerves of the human body and cause epilepsy and seizures, Parkinson's disease, dementia, autism, Alzheimer's disease, brain tumors, and cerebral palsy, among others. The prevalence of neurological disorders is increasing across the world. According to the Global Burden of Disease Study (GBD) 2017, Alzheimer’s disease and other dementias [2.55 million Disability Adjusted Life Years (DALYs)], stroke [about 3.58 million DALYs], and migraine (about 2.40 million DALYs) were the three most burdensome neurological diseases in the US in terms of a total number of disability-adjusted life.
Further, the Alzheimer's Association estimates that over 6 million Americans have Alzheimer's disease, and the number is projected to reach nearly 13 million by 2050. Transcranial Magnetic Stimulator (TMS) is widely used for the diagnosis and treatment of neurological disorders. For instance, according to BrainsWay Ltd., in April 2021, 100,000 patients across the world were treated with its Deep TMS. Thus, the growing prevalence of neurological disorders drives the growth of the transcranial magnetic stimulator (TMS) market globally. Moreover, depression is one of the mental disorders observed commonly among people worldwide. As per the data published by WHO in January 2020, more than 264 million people of all ages suffer from depression across the world.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Transcranial Magnetic Stimulator (TMS) Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Transcranial Magnetic Stimulator (TMS) Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Transcranial magnetic stimulation (TMS) is a noninvasive procedure that helps in treating neurological disorders. In addition, growing technological developments in TMS have increased its applications. Companies operating in the transcranial magnetic stimulator (TMS) market are adopting various strategies such as receiving Food and Drug Administration (FDA) approvals for their innovative products, business partnerships, and raising funds for product development, which propel the market growth.
The following are a few examples of developments:
- In March 2021, MagVenture introduced the MagVenture Flow Arm—a patent-pending, clinical positioning system—designed to optimize the delivery of MagVenture's FDA-cleared protocols for noninvasive brain stimulation technology for the treatment of major depressive disorder and as an adjunct therapy for obsessive compulsive disorder (OCD).
- In August 2020, MagVenture TMS Therapy received FDA clearance for the adjunct treatment of OCD. It is the second indication in the US for the Danish medical device company MagVenture.
- In February 2019, eNeura, Inc., a privately held medical technology company, announced a new 510(k) clearance from FDA. With the clearance, the company claimed that the sTMS is the only migraine product in the US for the treatment of acute and prophylactic migraine headaches in adults and children (12 years and above).
Thus, the active involvement of the global players in the development of transcranial magnetic stimulation and related technologies is expected to support the market growth.
Type-Based Insights
Based on type, the transcranial magnetic stimulator (TMS) market is segmented into single or paired pulse TMS and repetitive TMS (rTMS). In 2021, the single or paired pulse TMS segment held a larger share of the market. However, the repetitive TMS (rTMS) segment is expected to witness a higher CAGR during 2021–2028.
Application-Based Insights
Based on application, the market is segmented into research, diagnostic, and therapeutic. In 2021, the diagnostic segment held the largest share of the market and is expected to grow at the highest CAGR during the coming years.
Companies operating in the transcranial magnetic stimulator (TMS) market emphasize on adopting the strategy of product innovations to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Transcranial Magnetic Stimulator Transcranial Magnetic Stimulator (TMS) Market Regional Insights
The regional trends and factors influencing the Transcranial Magnetic Stimulator (TMS) Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Transcranial Magnetic Stimulator (TMS) Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Transcranial Magnetic Stimulator (TMS) Market
Transcranial Magnetic Stimulator (TMS) Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1.12 Billion |
| Market Size by 2028 | US$ 2.03 Billion |
| Global CAGR (2021 - 2028) | 8.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Transcranial Magnetic Stimulator (TMS) Market Players Density: Understanding Its Impact on Business Dynamics
The Transcranial Magnetic Stimulator (TMS) Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Transcranial Magnetic Stimulator (TMS) Market are:
- BrainsWay Ltd
- Nexstim
- Magstim
- Neuronetics
- TMS Neuro Solutions
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Transcranial Magnetic Stimulator (TMS) Market top key players overview
Transcranial Magnetic Stimulator (TMS) Market – Segmentation
By Type
- Single or Paired Pulse TMS
- Repetitive TMS (rTMS)
By Age Group
- Adults
- Children
By Application
- Research
- Diagnostic
- Therapeutic
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- BrainsWay Ltd
- Nexstim, Magstim
- Neuronetics
- TMS Neuro Solutions
- MagVenture, Inc.
- eNeura Inc.
- Neurosoft
- MAG & More GmbH
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ); Age Group ; Application , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Which region is the fastest growing the Transcranial Magnetic Stimulator (TMS) market?
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to large geriatric population, rising numbers of neurological disorders are among the factors expected to drive the market in the region during the forecast period.
Which segment is dominating the Transcranial Magnetic Stimulator (TMS) market?
The global Transcranial Magnetic Stimulator (TMS) market based on type is segmented into Single or paired pulse TMS and Repetitive TMS (rTMS). In 2021, the Single or paired pulse TMS segment held the largest share of the market, by type. The Repetitive TMS (rTMS) segment of Transcranial Magnetic Stimulator (TMS) market is also expected to witness fastest CAGR during 2021 to 2028..
Who are the major players in the Transcranial Magnetic Stimulator (TMS) market?
The Transcranial Magnetic Stimulator (TMS) market majorly consists of the players such as BrainsWay Ltd, Nexstim, Magstim, Neuronetics, TMS Neuro Solutions, MagVenture, Inc., eNeura Inc., Neurosoft, MAG & More GmbH. REMED among others amongst others.
Which country is dominated the Transcranial Magnetic Stimulator (TMS) market?
The US is the largest market for Transcranial Magnetic Stimulator (TMS) at a global level. The US is the largest and fastest-growing market for the TMS market. The market growth is attributed to increasing developments of the medical device sector for neuromodulation, significantly rising incidences of neurological disorders among people and growing demand for neuromodulation devices for chronic pain management. In addition, the economic burden to treat neurological disorders is significantly growing in the country. For instance, according to a study published by the American Neurological Association in March 2017, ~US$ 800 billion is spent per year for treating neurological disorders. The cost of treatment affects ~100 million people every year across the country. It is also estimated that the treatment cost of dementia and stroke alone is estimated to reach over US$ 600 billion in 2030.
What are the driving factors for the Transcranial Magnetic Stimulator (TMS) market across the globe?
The factors that are driving and restraining factors that will affect Transcranial Magnetic Stimulator (TMS) market in the coming years. Factors such as rising prevalence of neurological disorders, growing developments in transcranial magnetic stimulation technology are driving the market growth. However, high cost of diagnostic and treatment are likely to hamper the growth of the market.
What is Transcranial Magnetic Stimulator (TMS)?
Transcranial Magnetic Stimulator (TMS), also referred to us repetitive Transcranial Magnetic Stimulator (rTMS), is a type of brain stimulation in which a changing magnetic field is applied to a specific area of the brain. An electric pulse stimulator is attached to a magnetic coil, which is then connected to the scalp. It is a non-invasive procedure and is used for diagnostic and therapeutic applications.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Transcranial Magnetic Stimulator (TMS) Market
- BrainsWay Ltd
- Nexstim
- Magstim
- Neuronetics
- TMS Neuro Solutions
- MagVenture, Inc.
- eNeura Inc.
- Neurosoft
- MAG & More GmbH.
- REMED
Get Free Sample For